Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-18-017794

President and CEO sold 85,536 shares at an average $9.28 ($793,907)

From the SEC's structured data for this filing

Trades in this filing

Pomerantz Roger · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-20 Sale : show line 1 in the form −26,492 $9.33 $247,051 297,812 D
2018-06-21 Sale : show line 2 in the form −18,987 $9.06 $172,094 278,825 D
2018-06-22 Sale : show line 3 in the form −40,057 $9.36 $374,761 238,768 D
Open-market sales · 85,536 sh · avg $9.28 · $793,907
Loading xslF345X03/doc4.xml…